MR detects pancreatic islet inflammation in type 1 diabetes

Article

CONTEXT: In type 1 diabetes, the body's immune system mistakenly launches an attack on insulin-producing beta cells, sending T cells to invade pancreatic islets. Until recently, physicians could track type 1 diabetes only by monitoring blood levels of antibodies directed against pancreatic islet proteins. The test, however, usually detected type 1 diabetes late in its progression, after most islet beta cells had been destroyed and autoimmune processes had been played out. Researchers at Massachusetts General Hospital and Boston's Joslin Diabetes Center are using magnetofluorescence contrast nanoparticles, monitored with high-field MR, to devise a better test. It measures the permeability of the small blood vessels surrounding and within the islets, an early marker of this inflammation.

RESULTS: The technique has been successfully tested on a mouse model. For imaging, long-circulating magnetofluorescent nanoparticles were used. They consist of a superparamagnetic iron oxide (SPIO) core, a crosslinked dextran coating, and amino groups to which Alexa-488 fluorochrome is attached. Transgenic mice were imaged with an 8.5T micro-MR scanner 24 hours after contrast injection. Contrast accumulation was monitored in vivo, and a positive correlation between probe accumulation and insulitis was documented.

IMAGE: Higher MR relativities were measured in the pancreas of normal mice compared with diabetic mice 24 hours after contrast injection. (Image reprinted with permission of Proceedings of the National Academy of Science)

IMPLICATIONS: This imaging strategy may prove invaluable in helping identify early insulitis and for monitoring therapeutic interventions aimed at stopping its progression. MGH has already safely used the method in human clinical trials to detect the spread of prostate cancers to the lymph nodes.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.